Kolexia
Navellou Jean-Christophe Médecine interne
Navellou Jean-Christophe
Médecine interne
Hôpital Jean-Minjoz
Besançon, France
52 Activités
20 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Choc Maladie grave Choc septique Sepsie Aspergillose COVID-19 Aspergillose pulmonaire invasive Infection croisée Mucormycose

Collaborateurs

Voir plus
Piton Gael
Piton Gael
Hôpital Jean-Minjoz, Besançon, France
Capellier Gilles
Capellier Gilles
Hôpital Jean-Minjoz, Besançon, France
Cousson Joel
Cousson Joel
Hôpital Robert-Debré Reims, Reims, France
Timsit Jean-Francois
Timsit Jean-Francois
Hôpital Bichat-Claude-Bernard, Paris, France

Industries

Voir plus
PASCALEO
2 collaboration(s)
Dernière en 2019
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in severe SARS-CoV-2 pneumonia: a multicentre randomized controlled trial.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases   18 janvier 2023
Refractory invasive pulmonary aspergillosis due to Aspergillus flavus detected with the combination of two in-house Aspergillus qPCR.
Journal de mycologie medicale   09 novembre 2022
Investigation of the value of precipitins in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients with a positive marker for Aspergillus species.
Medical mycology   02 juin 2022
Proglegio: Bacterial and Human Biomarkers of Prognostic Value for Severe Legionnaire's Disease
Essai Clinique (Hospices Civils de Lyon)   04 mai 2022
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases   26 mai 2021
New clinical algorithm including fungal biomarkers to better diagnose probable invasive pulmonary aspergillosis in ICU.
Annals of intensive care   08 mars 2021
Mixed mold infection with and in a severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) patient.
Infectious diseases now   27 janvier 2021
Mucormycosis in intensive care unit: surgery is a major prognostic factor in patients with hematological malignancy.
Annals of intensive care   08 juin 2020
Zygomycosis in Intensive care unit- surgery as a major prognostic factor
Proceedings of Réanimation 2019, the French Intensive Care Society International Congress   29 mars 2019
The pharmacokinetic challenge of treating invasive aspergillosis complicating severe influenzae assisted by extracorporeal membrane oxygenation.
Critical care (London, England)   22 décembre 2018